ÂÜÀòÂÒÂ×

Peter Slavin, MD, currently serves as the President and CEO of Cedars-Sinai since October 2024. As a member of the National Academy of Medicine and a fellow at the American Academy of Arts & Sciences, Slavin is actively engaged in the medical community. Prior roles include Professor of Health Care Policy, from which Slavin is retired, at Harvard Medical School. Additionally, Slavin holds various advisory and board positions at companies such as Amwell, Tredence Inc., Droplet Biosciences, Inc., Florence, Perry Health, and Arsenal Capital Partners. Slavin's educational background includes a Doctor of Medicine from Harvard Medical School, a Master of Business Administration from Harvard Business School, and a Bachelor of Arts in Biochemical Sciences from Harvard University.